Anktiva is combined with BCG, or Bacillus Calmette-Guérin, an immunotherapy drug delivered to the bladder through a catheter.
AstraZeneca’s Imfinzi approved in US as first and only perioperative immunotherapy for patients with early gastric and GEJ cancers: Cambridge, UK Thursday, November 27, 2025, 09 ...
NEW YORK CITY, NY / ACCESS Newswire / November 26, 2025 / There are rooms where the future whispers. Yesterday at the 2025 DMCC Precious Metals Conference, it did not whisper. It stared the global ...
Start your day with a light meal, unless your doctor has said otherwise. Be sure to dress comfortably and wear something that ...
The FDA has approved AstraZeneca’s IMFINZI combined with standard FLOT chemotherapy for adults with resectable, early-stage ...
FDA approves AstraZeneca's Imfinzi plus FLOT for early gastric and GEJ cancers after Phase 3 data show strong event-free and ...
Imfinzi is the first immunotherapy approved for perioperative use to treat gastric and gastroesophageal junction cancers.
The US Food and Drug Administration approved AstraZeneca’s Imfinzi (durvalumab) with fluorouracil, leucovorin, oxaliplatin, ...
Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy ...
The US FDA has approved a durvalumab (Imfinzi, AstraZeneca)-based regimen for adults with resectable gastric or gastroesophageal junction adenocarcinoma (GC/GEJC). Specifically, durvalumab, an ...
Today, the FDA approved durvalumab (Imfinzi; AstraZeneca) in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy as a neoadjuvant and adjuvant treatment, followed ...
The FDA has approved durvalumab (Imfinzi) plus fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for the treatment ...